Completed

There are four phases that mesothelioma clinical trials go through. In Phase I new mesothelioma drugs or treatments are tested in a small group of participants. Phase II evaluates the same drug or treatment therapy in a larger group. Phase III involves an even larger population of participants and Phase IV takes place post licensing and marketing of a new drug or treatment. The clinical trials listed below have completed. Please click on a link to learn more about the study and the study results.

• Sunitinib in Treating Patients With Advanced Malignant Pleural Mesothelioma

  Conditions:

  Advanced Malignant Mesothelioma; Recurrent Malignant Mesothelioma

  Last Updated:

  May 15, 2013

  Status:

  Completed

• Phase I Study of Gene Induction Mediated by Sequential Decitabine/Depsipeptide Infusion With or Without Concurrent Celecoxib in Subjects With Pulmonary and Pleural Malignancies

  Conditions:

  Small Cell Carcinoma; Mesothelioma; Non-Small-Cell Lung Carcinoma

  Last Updated:

  May 1, 2013

  Status:

  Completed

• Depsipeptide/Flavopiridol Infusion for Cancers of the Lungs, Esophagus, Pleura, Thymus or Mediastinum

  Conditions:

  Carcinoma, Small Cell; Carcinoma, Non-small-cell Lung; Esophageal Neoplasms; Mesothelioma

  Last Updated:

  May 1, 2013

  Status:

  Completed

• Dasatinib in Treating Patients With Previously Treated Malignant Mesothelioma

  Conditions:

  Malignant Mesothelioma

  Last Updated:

  April 29, 2013

  Status:

  Completed

• A Single-Dose Pilot Study of Radiolabeled Amatuximab (MORAb-009) in Mesothelin Over Expressing Cancers

  Conditions:

  Mesothelioma; Pancreatic Cancer; Ovarian Cancer; Non-small Cell Lung Cancer

  Last Updated:

  April 23, 2013

  Status:

  Completed

• Bortezomib and Cisplatin as First-Line Therapy in Treating Patients With Malignant Mesothelioma

  Conditions:

  Malignant Mesothelioma

  Last Updated:

  April 19, 2013

  Status:

  Completed

• Cisplatin, Interferon Alfa, Surgery, and Radiation Therapy in Treating Patients With Malignant Pleural Mesothelioma

  Conditions:

  Malignant Mesothelioma

  Last Updated:

  April 16, 2013

  Status:

  Completed

• E-MOSAIC Electronic Tool to Monitor Symptoms

  Conditions:

  Cancer

  Last Updated:

  April 9, 2013

  Status:

  Completed

• Survival of Peritoneal Mesothelioma After Cytoreductive Surgery and Hyperthermic Intra-peritoneal Chemotherapy (HIPEC)

  Conditions:

  Peritoneal Mesotheliomas

  Last Updated:

  March 15, 2013

  Status:

  Completed

• Vaccine Therapy and GM-CSF in Treating Patients With Acute Myeloid Leukemia, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, or Mesothelioma

  Conditions:

  Leukemia; Lung Cancer; Malignant Mesothelioma; Myelodysplastic Syndromes; Primary Peritoneal Cavity Cancer

  Last Updated:

  March 6, 2013

  Status:

  Completed

• SU5416 in Treating Patients With Malignant Mesothelioma

  Conditions:

  Malignant Mesothelioma

  Last Updated:

  March 1, 2013

  Status:

  Completed

• Phase II Study of Valproate and Doxorubicin in Malignant Mesothelioma

  Conditions:

  Malignant Mesothelioma

  Last Updated:

  January 29, 2013

  Status:

  Completed

• Bortezomib in Treating Patients With Malignant Pleural Mesothelioma

  Conditions:

  Malignant Mesothelioma

  Last Updated:

  January 24, 2013

  Status:

  Completed

• Erlotinib in Treating Patients With Malignant Mesothelioma of the Lung

  Conditions:

  Advanced Malignant Mesothelioma; Epithelial Mesothelioma; Recurrent Malignant Mesothelioma; Sarcomatous Mesothelioma

  Last Updated:

  January 23, 2013

  Status:

  Completed

• Gefitinib in Treating Patients With Malignant Mesothelioma

  Conditions:

  Advanced Malignant Mesothelioma; Epithelial Mesothelioma; Recurrent Malignant Mesothelioma; Sarcomatous Mesothelioma

  Last Updated:

  January 15, 2013

  Status:

  Completed

• Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney Dysfunction

  Conditions:

  Adult Anaplastic Astrocytoma; Adult Anaplastic Ependymoma; Adult Anaplastic Oligodendroglioma; Adult Brain Stem Glioma; Adult Diffuse Astrocytoma; Adult Ependymoblastoma; Adult Giant Cell Glioblastoma; Adult Glioblastoma; Adult Gliosarcoma; Adult Mixed Glioma; Adult Myxopapillary Ependymoma; Adult Oligodendroglioma; Adult Pilocytic Astrocytoma; Adult Primary Hepatocellular Carcinoma; Adult Subependymoma; Advanced Adult Primary Liver Cancer; Advanced Malignant Mesothelioma; Male Breast Cancer; Recurrent Adenoid Cystic Carcinoma of the Oral Cavity; Recurrent Adult Brain Tumor; Recurrent Adult Primary Liver Cancer; Recurrent Anal Cancer; Recurrent Basal Cell Carcinoma of the Lip; Recurrent Bladder Cancer; Recurrent Breast Cancer; Recurrent Cervical Cancer; Recurrent Colon Cancer; Recurrent Esophageal Cancer; Recurrent Esthesioneuroblastoma of the Paranasal Sinus and Nasal Cavity; Recurrent Inverted Papilloma of the Paranasal Sinus and Nasal Cavity; Recurrent Lymphoepithelioma of the Nasopharynx; Recurrent Lymphoepithelioma of the Oropharynx; Recurrent Malignant Mesothelioma; Recurrent Metastatic Squamous Neck Cancer With Occult Primary; Recurrent Midline Lethal Granuloma of the Paranasal Sinus and Nasal Cavity; Recurrent Mucoepidermoid Carcinoma of the Oral Cavity; Recurrent Non-small Cell Lung Cancer; Recurrent Ovarian Epithelial Cancer; Recurrent Pancreatic Cancer; Recurrent Prostate Cancer; Recurrent Rectal Cancer; Recurrent Salivary Gland Cancer; Recurrent Squamous Cell Carcinoma of the Hypopharynx; Recurrent Squamous Cell Carcinoma of the Larynx; Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity; Recurrent Squamous Cell Carcinoma of the Nasopharynx; Recurrent Squamous Cell Carcinoma of the Oropharynx; Recurrent Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity; Recurrent Verrucous Carcinoma of the Larynx; Recurrent Verrucous Carcinoma of the Oral Cavity; Stage II Esophageal Cancer; Stage II Pancreatic Cancer; Stage III Esophageal Cancer; Stage III Pancreatic Cancer; Stage IIIB Non-small Cell Lung Cancer; Stage IV Adenoid Cystic Carcinoma of the Oral Cavity; Stage IV Anal Cancer; Stage IV Basal Cell Carcinoma of the Lip; Stage IV Bladder Cancer; Stage IV Breast Cancer; Stage IV Colon Cancer; Stage IV Esophageal Cancer; Stage IV Esthesioneuroblastoma of the Paranasal Sinus and Nasal Cavity; Stage IV Inverted Papilloma of the Paranasal Sinus and Nasal Cavity; Stage IV Lymphoepithelioma of the Nasopharynx; Stage IV Lymphoepithelioma of the Oropharynx; Stage IV Midline Lethal Granuloma of the Paranasal Sinus and Nasal Cavity; Stage IV Mucoepidermoid Carcinoma of the Oral Cavity; Stage IV Non-small Cell Lung Cancer; Stage IV Ovarian Epithelial Cancer; Stage IV Pancreatic Cancer; Stage IV Prostate Cancer; Stage IV Rectal Cancer; Stage IV Salivary Gland Cancer; Stage IV Squamous Cell Carcinoma of the Hypopharynx; Stage IV Squamous Cell Carcinoma of the Larynx; Stage IV Squamous Cell Carcinoma of the Lip and Oral Cavity; Stage IV Squamous Cell Carcinoma of the Nasopharynx; Stage IV Squamous Cell Carcinoma of the Oropharynx; Stage IV Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity; Stage IV Verrucous Carcinoma of the Larynx; Stage IV Verrucous Carcinoma of the Oral Cavity; Stage IVA Cervical Cancer; Stage IVB Cervical Cancer; Unspecified Adult Solid Tumor, Protocol Specific; Untreated Metastatic Squamous Neck Cancer With Occult Primary

  Last Updated:

  January 15, 2013

  Status:

  Completed

• Sorafenib Tosylate in Treating Patients With Malignant Mesothelioma.

  Conditions:

  Epithelial Mesothelioma; Recurrent Malignant Mesothelioma; Sarcomatous Mesothelioma; Stage IA Malignant Mesothelioma; Stage IB Malignant Mesothelioma; Stage II Malignant Mesothelioma; Stage III Malignant Mesothelioma; Stage IV Malignant Mesothelioma

  Last Updated:

  January 4, 2013

  Status:

  Completed

• Combination Chemotherapy With or Without Bevacizumab in Treating Patients With Malignant Mesothelioma

  Conditions:

  Advanced Malignant Mesothelioma; Epithelial Mesothelioma; Localized Malignant Mesothelioma; Recurrent Malignant Mesothelioma; Sarcomatous Mesothelioma

  Last Updated:

  December 21, 2012

  Status:

  Completed

• Study of CBP501 + Pemetrexed + Cisplatin on MPM (Phase I/II)

  Conditions:

  Malignant Pleural Mesothelioma; Solid Tumors

  Last Updated:

  December 19, 2012

  Status:

  Completed

• PXD101 as Second-Line Therapy in Treating Patients With Malignant Mesothelioma of the Chest That Cannot Be Removed By Surgery

  Conditions:

  Advanced Malignant Mesothelioma; Epithelial Mesothelioma; Recurrent Malignant Mesothelioma; Sarcomatous Mesothelioma

  Last Updated:

  December 11, 2012

  Status:

  Completed

• Pemetrexed Plus Gemcitabine or Carboplatin for Patients With Advanced Malignant Pleural Mesothelioma

  Conditions:

  Mesothelioma

  Last Updated:

  November 30, 2012

  Status:

  Completed

• Study of Oral PXD101 in Patients With Advanced Solid Tumors or Lymphoma

  Conditions:

  Solid Tumor; Lymphoma

  Last Updated:

  November 30, 2012

  Status:

  Completed

• Pharmacokinetic, Safety, and Efficacy Effects of Oral LBH589 on Dextromethorphan in Patients With Advanced or Metastatic Non-Small Cell Lung Cancer or Malignant Pleural Mesothelioma

  Conditions:

  Carcinoma, Non-Small-Cell Lung; Mesothelioma

  Last Updated:

  November 26, 2012

  Status:

  Completed

• Study of PXD101 Alone and in Combination With 5-Fluorouracil (5-FU) in Patients With Advanced Solid Tumors

  Conditions:

  Tumor

  Last Updated:

  November 8, 2012

  Status:

  Completed

• Sorafenib, Pemetrexed, and Cisplatin in Treating Patients With Advanced Solid Tumors

  Conditions:

  Breast Cancer; Colorectal Cancer; Head and Neck Cancer; Lung Cancer; Mesothelioma; Pancreatic Cancer; Prostate Cancer; Sarcoma

  Last Updated:

  November 6, 2012

  Status:

  Completed

• Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain

  Conditions:

  Cancer

  Last Updated:

  November 1, 2012

  Status:

  Completed

• S0509: AZD2171 in Treating Patients With Malignant Pleural Mesothelioma That Cannot Be Removed By Surgery

  Conditions:

  Malignant Mesothelioma

  Last Updated:

  October 30, 2012

  Status:

  Completed

• Anti-TGF Monoclonal Antibody (GC1008) in Relapsed Malignant Pleural Mesothelioma

  Conditions:

  Pleural Malignant Mesothelioma

  Last Updated:

  October 11, 2012

  Status:

  Completed

• S9810: Gemcitabine Plus Cisplatin in Treating Patients With Malignant Mesothelioma of the Pleura That Cannot Be Removed by Surgery

  Conditions:

  Malignant Mesothelioma

  Last Updated:

  October 5, 2012

  Status:

  Completed

• Everolimus (RAD001) for the Treatment of Malignant Pleural Mesothelioma With Merlin/NF2 Loss as a Biomarker to Predict Sensitivity

  Conditions:

  Malignant Pleural Mesothelioma

  Last Updated:

  September 19, 2012

  Status:

  Completed

• Radiofrequency Ablation in Treating Patients With Refractory or Advanced Lung Cancer

  Conditions:

  Lung Cancer; Malignant Mesothelioma; Metastatic Cancer; Thymoma and Thymic Carcinoma

  Last Updated:

  July 27, 2012

  Status:

  Completed

• Interleukin-12 in Treating Patients With Cancer in the Abdomen

  Conditions:

  Anal Cancer; Colorectal Cancer; Gallbladder Cancer; Gastric Cancer; Pancreatic Cancer

  Last Updated:

  July 27, 2012

  Status:

  Completed

• Treatment of Peritoneal Cancer With Surgery, Perfused Heated Cisplatin and Chemotherapy

  Conditions:

  Abdominal Neoplasm; Colonic Neoplasm; Mesothelioma; Peritoneal Neoplasm

  Last Updated:

  July 23, 2012

  Status:

  Completed

• Pemetrexed Disodium and Cisplatin Followed By Surgery and Radiation Therapy in Treating Patients With Malignant Pleural Mesothelioma

  Conditions:

  Malignant Mesothelioma

  Last Updated:

  July 17, 2012

  Status:

  Completed

• Raltitrexed in Treating Patients With Malignant Mesothelioma That Cannot Be Surgically Removed

  Conditions:

  Malignant Mesothelioma

  Last Updated:

  July 17, 2012

  Status:

  Completed

• Cisplatin With or Without Raltitrexed in Treating Patients With Malignant Mesothelioma of the Pleura

  Conditions:

  Malignant Mesothelioma

  Last Updated:

  July 17, 2012

  Status:

  Completed

• An Open-label, Phase II Trial of ZD1839 (IRESSA) in Patients With Malignant Mesothelioma

  Conditions:

  Mesothelioma

  Last Updated:

  June 5, 2012

  Status:

  Completed

• Combination Chemotherapy Before Surgery in Treating Patients With Mesothelioma of the Lung

  Conditions:

  Malignant Mesothelioma

  Last Updated:

  May 14, 2012

  Status:

  Completed

• Phase II Study of Imatinib Mesylate in Patients With Life Threatening Malignant Rare Diseases

  Conditions:

  Life Threatening Diseases

  Last Updated:

  April 18, 2012

  Status:

  Completed

• Suberoylanilide Hydroxamic Acid (Vorinostat, MK-0683) Versus Placebo in Advanced Malignant Pleural Mesothelioma (0683-014 AM5, EXT1)

  Conditions:

  Mesothelioma; Lung Cancer

  Last Updated:

  April 3, 2012

  Status:

  Completed

• Inhaled Doxorubicin in Treating Patients With Advanced Solid Tumors Affecting the Lungs

  Conditions:

  Lung Cancer; Malignant Mesothelioma; Metastatic Cancer

  Last Updated:

  March 14, 2012

  Status:

  Completed

• MS-275 in Treating Patients With Advanced Solid Tumors or Lymphoma

  Conditions:

  Cancer

  Last Updated:

  March 14, 2012

  Status:

  Completed

• Study of Previously Collected and Stored Tissue Samples From Patients Previously Enrolled in a Completed National Cancer Institute Clinical Trial

  Conditions:

  Cancer

  Last Updated:

  February 16, 2012

  Status:

  Completed

• Bevacizumab (Avastin) and Erlotinib (Tarceva) in Previously Treated Mesothelioma

  Conditions:

  Mesothelioma

  Last Updated:

  December 23, 2011

  Status:

  Completed

• B-Receptor Signaling in Cardiomyopathy

  Conditions:

  Carcinomas; Amyloidosis; Anal Cancer; Anemia; Cholangiocarcinoma of the Extrahepatic Bile Duct; Transitional Cell Carcinoma of Bladder; Bone Marrow Transplant Failure; Bone Cancer; Cancer of Brain and Nervous System; Breast Cancer; Carcinoma of the Large Intestine; Endocrine Cancer; Esophageal Cancer; Eye Cancer; Gall Bladder Cancer; Gastric (Stomach) Cancer; Gastrooesophageal Cancer; Gastrointestinal Stromal Tumor (GIST); Gynecologic Cancers; Head and Neck Cancers; Hepatobiliary Neoplasm; Kidney (Renal Cell) Cancer; Leukemia; Lung Cancer; Hodgkin Disease; Lymphoma, Non-Hodgkin; Mesothelioma; Multiple Myeloma; Myelodysplastic Syndromes (MDS); Neuroendocrine Tumors; Myeloproliferative Disorders; Pancreatic Cancer; Prostate Cancer; Skin Cancer; Soft Tissue Sarcoma; Testicular Cancer; Thymus Cancer; Thyroid Cancer

  Last Updated:

  October 31, 2011

  Status:

  Completed

• Phase I Study of OSI-930 and Erlotinib in Cancer Tumors

  Conditions:

  Advanced Solid Tumors

  Last Updated:

  September 26, 2011

  Status:

  Completed

• Phase II Study of Bevacizumab, Pemetrexed and Carboplatin as First-Line Therapy in Malignant Pleural Mesothelioma

  Conditions:

  Mesothelioma

  Last Updated:

  August 31, 2011

  Status:

  Completed

• Pemetrexed, Cisplatin, and Vitamin B12 in Treating Patients With Mesothelioma of the Chest That Cannot Be Removed by Surgery

  Conditions:

  Malignant Mesothelioma

  Last Updated:

  May 14, 2011

  Status:

  Completed

• Pemetrexed Plus Cisplatin Neoadjuvant Therapy Followed By Surgery and Radiation in Mesothelioma

  Conditions:

  Mesothelioma

  Last Updated:

  May 5, 2011

  Status:

  Completed

• Immunotoxin Therapy in Treating Patients With Advanced Solid Tumors

  Conditions:

  Cervical Cancer; Fallopian Tube Cancer; Head and Neck Cancer; Lung Cancer; Malignant Mesothelioma; Ovarian Cancer; Pancreatic Cancer; Primary Peritoneal Cavity Cancer

  Last Updated:

  April 23, 2011

  Status:

  Completed

• Immunotoxin Therapy in Treating Patients With Advanced Cancer

  Conditions:

  Cervical Cancer; Fallopian Tube Cancer; Head and Neck Cancer; Lung Cancer; Malignant Mesothelioma; Ovarian Cancer; Pancreatic Cancer; Primary Peritoneal Cavity Cancer

  Last Updated:

  April 23, 2011

  Status:

  Completed

• PV701 in Treating Patients With Advanced or Recurrent Peritoneal Cancer

  Conditions:

  Cancer

  Last Updated:

  April 23, 2011

  Status:

  Completed

• A Study To Find The Best Dose Of SU011248 When Given With Pemetrexed, Pemetrexed And Cisplatin Or Pemetrexed And Carboplatin In Patients With Advanced Solid Tumors

  Conditions:

  Neoplasms

  Last Updated:

  April 7, 2011

  Status:

  Completed

• Capecitabine in Treating Patients With Malignant Mesothelioma

  Conditions:

  Malignant Mesothelioma

  Last Updated:

  April 1, 2011

  Status:

  Completed

• Liposomal-Cisplatin Analogue (L-NDDP) in Treating Patients With Malignant Pleural Mesothelioma

  Conditions:

  Malignant Mesothelioma

  Last Updated:

  March 25, 2011

  Status:

  Completed

• PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma

  Conditions:

  Malignant Mesothelioma

  Last Updated:

  March 17, 2011

  Status:

  Completed

• Vaccine Therapy in Treating Patients With Stage I, Stage II, or Stage IIIA Non-small Cell Lung Cancer or With Stage I or Stage II Mesothelioma

  Conditions:

  Lung Cancer; Malignant Mesothelioma

  Last Updated:

  March 3, 2011

  Status:

  Completed

• Biomarkers of Angiogenesis and Disease in Patients With Unresectable Malignant Mesothelioma Treated on Clinical Trial CALGB-30107

  Conditions:

  Malignant Mesothelioma

  Last Updated:

  March 1, 2011

  Status:

  Completed

• Surgery and Photodynamic Therapy in Treating Patients With Malignant Mesothelioma

  Conditions:

  Malignant Mesothelioma

  Last Updated:

  February 25, 2011

  Status:

  Completed

• Gemcitabine in Long Infusion and Cisplatin for Malignant Pleural Mesothelioma Treatment

  Conditions:

  Malignant Pleural Mesothelioma

  Last Updated:

  November 17, 2010

  Status:

  Completed

• Dendritic Cell-based Immunotherapy in Mesothelioma

  Conditions:

  Malignant Pleural Mesothelioma

  Last Updated:

  November 15, 2010

  Status:

  Completed

• Cisplatin, Pemetrexed and Bevacizumab for Untreated Malignant Mesothelioma

  Conditions:

  Mesothelioma

  Last Updated:

  August 16, 2010

  Status:

  Completed

• Safety and Immune Response to a Multi-component Immune Based Therapy (MKC1106-PP) for Patients With Advanced Cancer.

  Conditions:

  Ovarian; Melanoma; Renal; Prostate; Colorectal; Endometrial Carcinoma; Cervical Carcinoma; Testicular Cancer; Thyroid Cancer; Small Cell Lung Carcinoma; Mesothelioma; Breast Carcinoma; Esophageal Carcinoma; Gastric Cancer; Pancreatic Carcinoma; Neuroendocrine Cancer; Liver Cancer; Gallbladder Cancer; Biliary Tract Cancer; Anal Carcinoma; Bone Sarcomas; Soft Tissue Sarcomas; Carcinoma of Unknown Origin, Primary

  Last Updated:

  August 2, 2010

  Status:

  Completed

• Study of Pemetrexed in Mesothelioma and Lung Cancer Patients With Fluid Around the Lungs or Abdomen

  Conditions:

  Non-small Cell Lung Cancer; Mesothelioma; Lung Neoplasms

  Last Updated:

  June 10, 2010

  Status:

  Completed

• Neoadjuvant Pemetrexed Disodium and Cisplatin Followed by Surgery and Radiation Therapy in Treating Patients With Pleural Mesothelioma

  Conditions:

  Malignant Mesothelioma

  Last Updated:

  December 16, 2009

  Status:

  Completed

• Alanosine in Treating Patients With Cancer

  Conditions:

  Lung Cancer; Malignant Mesothelioma; Pancreatic Cancer; Sarcoma

  Last Updated:

  December 11, 2009

  Status:

  Completed

• Study of Carboplatin and Vinorelbine in Malignant Pleural Mesothelioma

  Conditions:

  Malignant Pleural Mesothelioma

  Last Updated:

  September 17, 2009

  Status:

  Completed

• Cyclophosphamide Plus Vaccine Therapy in Treating Patients With Advanced Cancer

  Conditions:

  Breast Cancer; Colorectal Cancer; Kidney Cancer; Lung Cancer; Malignant Mesothelioma; Pancreatic Cancer

  Last Updated:

  June 11, 2009

  Status:

  Completed

• Phase II Trial of Neo-Adjuvant Pemetrexed Plus Cisplatin Followed by Surgery and Radiation for Pleural Mesothelioma

  Conditions:

  Pleural Neoplasms

  Last Updated:

  May 1, 2009

  Status:

  Completed

• Combination Chemotherapy and Tamoxifen in Treating Patients With Solid Tumors

  Conditions:

  Adrenocortical Carcinoma; Brain and Central Nervous System Tumors; Head and Neck Cancer; Liver Cancer; Malignant Mesothelioma; Pheochromocytoma; Sarcoma

  Last Updated:

  February 6, 2009

  Status:

  Completed

• Decitabine in Treating Patients With Unresectable Lung or Esophageal Cancer or Malignant Mesothelioma of the Pleura

  Conditions:

  Esophageal Cancer; Lung Cancer; Malignant Mesothelioma; Metastatic Cancer

  Last Updated:

  December 13, 2008

  Status:

  Completed

• A Study of MORAb-009 in Subjects With Pancreatic Cancer, Mesothelioma, or Certain Types of Ovarian or Lung Cancer

  Conditions:

  Pancreatic Cancer; Mesothelioma; Ovarian Cancer; Non-Small Cell Lung Cancer

  Last Updated:

  December 2, 2008

  Status:

  Completed

• Gemcitabine and Epirubicin in Treating Patients With Malignant Mesothelioma

  Conditions:

  Malignant Mesothelioma

  Last Updated:

  July 23, 2008

  Status:

  Completed

• Ecteinascidin 743 in Treating Patients With Malignant Mesothelioma

  Conditions:

  Malignant Mesothelioma

  Last Updated:

  July 23, 2008

  Status:

  Completed

• Cisplatin With or Without Pemetrexed Disodium in Treating Patients With Malignant Mesothelioma of the Pleura That Cannot be Removed by Surgery

  Conditions:

  Malignant Mesothelioma

  Last Updated:

  July 23, 2008

  Status:

  Completed

• Rigid Thoracoscopy Versus CT-Guided Pleural Needle Biopsy

  Conditions:

  Pleural Effusion; Pleural Diseases

  Last Updated:

  July 22, 2008

  Status:

  Completed

• Study of Pemetrexed Plus Cisplatin in Patients With Malignant Pleural Mesothelioma

  Conditions:

  Malignant Pleural Mesotherioma

  Last Updated:

  November 5, 2007

  Status:

  Completed

• Safety Confirmation Study of Pemetrexed Plus Cisplatin in Patients With Malignant Pleural Mesothelioma

  Conditions:

  Malignant Pleural Mesothelioma

  Last Updated:

  April 10, 2007

  Status:

  Completed

• A Study Comparing Pemetrexed Plus Best Supportive Care Versus Best Supportive Care Alone in the Treatment of Mesothelioma

  Conditions:

  Mesothelioma

  Last Updated:

  January 24, 2007

  Status:

  Completed

• Pemetrexed Plus Gemcitabine as Front-Line Chemotherapy for Patients With Malignant Pleural or Peritoneal Mesothelioma

  Conditions:

  Mesothelioma

  Last Updated:

  January 24, 2007

  Status:

  Completed